The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results

Luciano Quaranta, Elena Biagioli, Ivano Riva, Francesca Galli, Davide Poli, Eliana Rulli, Andreas Katsanos, Antonio Longo, Maurizio G Uva, Francesco Oddone, Valter Torri, Robert N Weinreb

Research output: Contribution to journalArticlepeer-review


PURPOSE: To investigate the efficacy and safety of a treatment strategy with latanoprost and dorzolamide in primary pediatric glaucoma patients partially responsive to surgery.PATIENTS AND METHODS: Children with primary pediatric glaucoma with postsurgical intraocular pressure (IOP) between 22 and 26 mm Hg were eligible. At baseline, patients were administered latanoprost once daily. Depending on IOP reduction, patients were allocated to continuation of latanoprost monotherapy or addition of dorzolamide twice daily, or switch to dorzolamide monotherapy 3 times daily. Patients in the dorzolamide monotherapy group with IOP reduction
Original languageItalian
Pages (from-to)856-863
Number of pages8
JournalJournal of Glaucoma
Issue number10
Publication statusPublished - Oct 2018

Cite this